Fortitude Family Office, LLC

Family Office

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1950506 SCOTTSDALE, AZ

Position in XERS

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$11,880

+$2,873 QoQ

Shares Held

1,500

-3.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#203

of 238 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortitude Family Office, LLC holds $231,944 across 21 Drug Manufacturers - Specialty & Generic names. XERS ranks #8 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	2,964	$47,068
2	UTHR	UNITED THERAPEUTICS Corp	64	$34,677
3	NBIX	Neurocrine Biosciences Inc	174	$29,325
4	LQDA	Liquidia Corp	327	$26,071
5	HIMS	Hims & Hers Health, Inc.	637	$22,084
6	KNSA	Kiniksa Pharmaceuticals International, plc	249	$15,923
7	AMRX	Amneal Pharmaceuticals, Inc.	800	$13,848
8	XERS	Xeris Biopharma Holdings, Inc. This page	1,500	$11,880

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,880	1,500	-3.4%	Shares	Sole	2026-07-20
2026-03-31	$9,007	1,553	0.0%	Shares	Sole	2026-04-16
2025-12-31	$12,191	1,553	0.0%	Shares	Sole	2026-01-15
2025-09-30	$12,641	1,553	0.0%	Shares	Sole	2025-10-17
2025-06-30	$7,252	1,553	-7.1%	Shares	Sole	2025-07-15
2025-03-31	$9,173	1,671	0.0%	Shares	Sole	2025-04-16
2024-12-31	$5,664	1,671	0.0%	Shares	Sole	2025-01-10
2024-09-30	$4,762	1,671	0.0%	Shares	Sole	2024-10-25
2024-06-30	$3,759	1,671	-27.6%	Shares	Sole	2024-07-10
2024-03-31	$5,102	2,309	0.0%	Shares	Sole	2024-04-11
2023-12-31	$5,426	2,309	—	Shares	Sole	2024-01-12
No filing history on record for this holder in this stock.